Endovasc Inactive 10-Q2006 Q3 Quarterly report

Filed: 15 Nov 06, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: adding, adjustment, allocated, angioplasty, animal, appeal, arisen, Arnold, ascertainable, aspirin, attention, attorney, blind, Boston, bringing, Bulletin, care, CFO, cholesterol, chosen, Cilostazol, Classic, clause, clopidogrel, combination, combined, competition, compliance, component, compound, conceptualize, conclusion, conduct, conducted, consent, conserved, Cook, correct, covered, CR, currency, demonstrate, DES, device, disclosed, discontinue, discovery, distance, dollar, double, drinking, duly, efficacy, embodied, encapsulated, Endothil, enter, entered, enterprise, establish, established, estate, exercise, expand, experimentation, extensive, fall, FASB, fat, favor, fed, functional, GNC, governmental, group, guidance, Guidant, healthy, identical, II, III, immaterial, improve, inception, incurred, IND, inflation, ischemia, ITEM, label, Lake, lead, leg, licensee, limb, low, lower, manner, manufacturing, medical, medication, metal, mice, minimum, mitigate, muscle, nationwide, obesity, occlusive, Open, outweigh, paclitaxol, people, placement, Plavix, policy, pressure, proceed, processing, profile, program, progression, proper, proprietary, prostaglandin, pursued, PVD, qualitative, quantify, quantifying, quantitative, readily, recommended, refusal, regimen, regulatory, relationship, relevant, remedy, renegotiated, royalty, SAB, safety, Salt, satisfy, Scientific, scientifically, seek, segregation, settle, small, smoking, sophisticated, stipulated, strength, sublicense, subscription, suitable, summarize, support, surgery, Surgical, taxol, technology, tolerance, uncorrected, underlying, undersigned, unique, urinary, Utah, vascular, walking, water, week, worldwide

Removed: AAA, absolute, acting, addition, alerting, arbitration, average, biopharmaceutical, Blumberg, canceled, claim, commercial, community, compartment, composed, conceived, COO, corporate, defendant, delivery, detected, durable, engineered, entitlement, entrap, European, event, expensed, fact, finance, fraud, greater, grow, hearing, highly, hollow, internally, leveraged, LIBOR, liposome, longer, managed, matter, mediation, met, microscopic, operated, outer, paper, prime, proceeding, ranging, reached, realization, recent, reception, recision, reflecting, regulate, regulated, rely, resource, return, sensitivity, settlement, successor, system, thin, transferred, transport, treated, unspecified, vFinance, weighted, wholly, work

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Endovasc similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

CERTIFICATION PURSUANT TO RULE 13a-14(b) OR

RULE 15d-14(b) and 18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Endovasc, Inc. (the "Company") on Form 10-Q for the period ended September 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, , Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: Nov 10, 2006	By:	/s/ Diane Dottavio
		Diane Dottavio
		Chief Financial Officer